Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023

Go back to Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023
(NASDAQ: ATRA) Delayed: 8.67 --0 (-0%)
Previous Close $8.67    52 Week High $40.80 
Open $8.67    52 Week Low $12.45 
Day High $8.67    P/E N/A 
Day Low $8.67    EPS $0.00 
Volume 21